KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Enterprise Value: 2009-2024

Historic Enterprise Value for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to $412.4 million.

  • Emergent BioSolutions' Enterprise Value fell 22.43% to $221.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$308.0 million, marking a year-over-year decrease of 1401.39%. This contributed to the annual value of $412.4 million for FY2024, which is 3116.21% up from last year.
  • Per Emergent BioSolutions' latest filing, its Enterprise Value stood at $412.4 million for FY2024, which was up 3,116.21% from $12.8 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Enterprise Value registered a high of $4.1 billion during FY2020, and its lowest value of -$53.4 million during FY2022.
  • For the 3-year period, Emergent BioSolutions' Enterprise Value averaged around $123.9 million, with its median value being $12.8 million (2023).
  • Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 103.03% in 2022, then soared by 3,116.21% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Enterprise Value (Yearly) stood at $4.1 billion in 2020, then plummeted by 57.30% to $1.8 billion in 2021, then plummeted by 103.03% to -$53.4 million in 2022, then surged by 124.00% to $12.8 million in 2023, then surged by 3,116.21% to $412.4 million in 2024.